Miller Howard Investments Inc Abb Vie Inc. Transaction History

Miller Howard Investments Inc

$3.22 Billion
Q3 2024

A detailed history of Miller Howard Investments Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Miller Howard Investments Inc holds 415,487 shares of ABBV stock, worth $74.8 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares

415,487

Previous 450,670 7.81%

Holding current value

$74.8 Million

Previous $77.3 Million 6.15%

% of portfolio

2.55%

Previous 2.58%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $5.76 Million - $7.01 Million	-35,183 Reduced 7.81%	415,487 $82.1 Million
Q2 2024 Jul 26, 2024	SELL	$154.79 - $180.76 $956,447 - $1.12 Million	-6,179 Reduced 1.35%	450,670 $77.3 Million
Q1 2024 Apr 12, 2024	SELL	$159.82 - $182.1 $1.05 Million - $1.19 Million	-6,544 Reduced 1.41%	456,849 $83.2 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $590,579 - $665,131	-4,292 Reduced 0.92%	463,393 $71.8 Million
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $554,665 - $642,106	4,152 Added 0.9%	467,685 $69.7 Million
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $27,562 - $34,299	208 Added 0.04%	463,533 $62.5 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $2.89 Million - $3.33 Million	-20,004 Reduced 4.14%	463,325 $73.8 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $583,668 - $699,971	-4,220 Reduced 0.87%	483,329 $78.2 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $16.6 Million - $19 Million	-123,626 Reduced 20.23%	487,549 $65.4 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $1.01 Million - $1.28 Million	7,330 Added 1.21%	611,175 $93.6 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $1.34 Million - $1.67 Million	-10,179 Reduced 1.66%	603,845 $97.9 Million
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $7.35 Million - $9.29 Million	68,379 Added 12.53%	614,024 $83.1 Million
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $2.15 Million - $2.44 Million	-20,211 Reduced 3.57%	545,645 $58.9 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $135,300 - $150,732	1,286 Added 0.23%	565,856 $63.7 Million
Q1 2021 Apr 16, 2021	SELL	$102.3 - $112.62 $1.11 Million - $1.22 Million	-10,869 Reduced 1.89%	564,570 $61.1 Million
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $3.46 Million - $4.68 Million	-43,022 Reduced 6.96%	575,439 $61.7 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $1.41 Million - $1.65 Million	-16,401 Reduced 2.58%	618,461 $54.2 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $1.18 Million - $1.57 Million	16,025 Added 2.59%	634,862 $62.3 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $6.29 Million - $9.54 Million	-97,534 Reduced 13.62%	618,837 $47.1 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $549,486 - $687,524	-7,618 Reduced 1.05%	716,371 $63.4 Million
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $37.9 Million - $45.5 Million	601,270 Added 489.96%	723,989 $54.8 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $8.06 Million - $10.3 Million	122,719 New	122,719 $8.92 Million
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $62.7 Million - $74.2 Million	-698,697 Closed	0 $0
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $2.31 Million - $3.09 Million	-25,059 Reduced 3.46%	698,697 $66.1 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $5.31 Million - $5.82 Million	-59,305 Reduced 7.57%	723,756 $70 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $54.7 Million - $69.9 Million	783,061	783,061 $69.6 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Howard Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Miller Howard Investments Inc with notifications on news.

Account

Miller Howard Investments Inc Abb Vie Inc. Transaction History